APA (7th ed.) Citation

Yang, Z. (2018). Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients. The American Association for Cancer Research (AACR).

Chicago Style (17th ed.) Citation

Yang, Z. Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients. The American Association for Cancer Research (AACR), 2018.

MLA (9th ed.) Citation

Yang, Z. Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients. The American Association for Cancer Research (AACR), 2018.

Warning: These citations may not always be 100% accurate.